Clinical Trial Update: A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA

View source ↗

Summary

A long-term follow-up study is evaluating intravenous EXG001-307 in patients with Type 1 spinal muscular atrophy; the study is currently enrolling by invitation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• EXG001-307

Snippet

Sponsor: Guangzhou Jiayin Biotech Ltd | Conditions: Spinal Muscular Atrophy | Status: ENROLLING_BY_INVITATION